Anna Balcerak

447 citations
17 papers · 304 indexed · h-index 10
Topics
RNA modifications and cancer (6 papers)Blood disorders and treatments (6 papers)Erythrocyte Function and Pathophysiology (5 papers)

In The Last Decade

Anna Balcerak

17 papers receiving 302 citations

Peers

Anna Balcerak
Comparison fields: 5 of 55
  • Molecular Biology 232
  • Cancer Research 115
  • Genetics 51
  • Physiology 38
  • Immunology 35
Replace Yuzhong Jeff Meng with:
Yuzhong Jeff Meng United States
Gabrijela Dumbović United States
David Piñeyro Spain
Zvezdan Pavlovic Canada
Yun Deng China
Ana Vilar Spain
Ruofan Ding China
Véronique Lisi Canada
Charlotte Beaver United Kingdom
Anna Balcerak relative to Yuzhong Jeff Meng United States Yuzhong Jeff Meng's profile →
Citations per field
00.5×10×15×22×
Yuzhong Jeff Meng · 1×
Citations per year

Countries citing papers authored by Anna Balcerak

Since Specialization
Citations

This map shows the geographic impact of Anna Balcerak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Balcerak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Balcerak more than expected).

Fields of papers citing papers by Anna Balcerak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Balcerak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Balcerak. The network helps show where Anna Balcerak may publish in the future.

Co-authorship network of co-authors of Anna Balcerak

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Balcerak. A scholar is included among the top collaborators of Anna Balcerak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Balcerak. Anna Balcerak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 4
2 3
3 25
4 2
5 11
6 9
7 13
8 13
9 78
10 4
11 7
12 6
13 16
14 44
15 50
16 12
17 7

About Anna Balcerak

Anna Balcerak is a scholar working on Geriatrics and Gerontology, Genetics and Cancer Research, having authored 17 papers that have together received 304 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Blood disorders and treatments (6 papers) and Erythrocyte Function and Pathophysiology (5 papers). The work is most often cited by research in Cancer Research (115 citations), Molecular Biology (232 citations) and Genetics (51 citations). Anna Balcerak has collaborated with scholars based in Poland, United States and United Kingdom. Frequent co-authors include Ewa A. Grzybowska, Ryszard Konopiński, Alicja Trębińska, Lukasz M. Szafron, Tymon Rubel, Agnieszka Dansonka‐Mieszkowska, Jolanta Kupryjańczyk, Bożena Konopka, Barbara Pieńkowska‐Grela and Agnieszka Podgórska. Their work appears in journals such as PLoS ONE, Proceedings of the IEEE and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026